Dr. Glenn Michaelson has more than 30 years of experience in the pharmaceutical and biotechnology industries, specializing in oncology and clinical trials. After receiving his B.A. in Chemistry, as well as an MD from the University of Louisville, he completed a residency in Internal Medicine at the University of Pittsburgh and a Medical Oncology/Hematology fellowship at the University of Chicago. Prior to Telo Therapeutics, Glenn served in a variety positions from Medical Director to Vice-President while working with numerous established Biopharma companies to include Agouron/Pfizer, Cell Therapeutics, Chiron, Sunesis Pharmaceuticals, Genentech, Portola Pharmaceuticals, Plexxicon and CytomX Therapeutics. He has extensive experience in all phases of oncology clinical development and medical affairs with small molecules, RTKI, cytotoxics, and biologics.
